NCT04322591View on ClinicalTrials.gov

Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial

RecruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

March 24, 2020

Primary Completion Date

December 24, 2024

Study Completion Date

March 24, 2025

Conditions

Non-small Cell Lung Cancer

Trial Locations (1)

410013

RECRUITING

Yongchang Zhang, Changsha

All Listed Sponsors

lead

Hunan Province Tumor Hospital

OTHER